Quick Answer
AtriCure, Inc. reported Long Term Debt of $61.87 million for the year ending 2025.
- AtriCure, Inc. showed an increase of +0.0% in Long Term Debt from 2024 to 2025.
- This data is from AtriCure, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2016: $24.97 million | Q3 2016: $25.02 million | Q1 2017: $22.15 million | Q2 2017: $20.42 million | Q3 2017: $18.69 million | Q1 2018: $39.31 million | Q2 2018: $39.40 million | Q3 2018: $38.55 million | Q1 2019: $32.74 million | Q2 2019: $33.89 million | Q3 2019: $59.52 million | Q1 2020: $58.32 million | Q2 2020: $54.15 million | Q3 2020: $49.99 million | Q1 2021: $48.55 million | Q2 2021: $43.67 million | Q3 2021: $56.35 million | Q1 2022: $59.85 million | Q2 2022: $59.95 million | Q3 2022: $60.06 million | Q1 2023: $51.94 million | Q2 2023: $47.05 million | Q3 2023: $42.15 million | Q1 2024: $61.87 million | Q2 2024: $61.87 million | Q3 2024: $61.87 million | Q1 2025: $61.87 million | Q2 2025: $61.87 million | Q3 2025: $61.87 million.
- Over the full 10 years of available data (2016 to 2025), AtriCure, Inc.'s Long Term Debt has grown by 159.0%.
- Historical annual values: Fiscal year 2025: $61.87 million | Fiscal year 2024: $61.87 million | Fiscal year 2023: $61.00 million | Fiscal year 2022: $56.83 million | Fiscal year 2021: $59.74 million | Fiscal year 2020: $53.44 million | Fiscal year 2019: $59.63 million | Fiscal year 2018: $35.57 million | Fiscal year 2017: $24.10 million | Fiscal year 2016: $23.89 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: